CSF Biomarkers and the Diagnosis of Variant Forms of Alzheimer's Disease

Progress in Neurology and Psychiatry - United Kingdom
doi 10.1002/pnp.465
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Should CSF Biomarkers Support a Routine Analysis for Early Diagnosis of Alzheimer's Disease?

International Journal of Alzheimer's Disease
AgingCognitive NeuroscienceMolecular NeuroscienceNeurologyBehavioral NeuroscienceCellular
2010English

Frontal Variant of Alzheimer's Disease: Clinico-CSF-Pathological Correlation

Canadian Journal of Neurological Sciences
MedicineNeurology
2010English

Biomarkers of Alzheimer's Disease

Neurobiology of Disease
Neurology
2009English

Cerebrospinal Fluid Tau and Phosphotau as Biomarkers in Alzheimer's Disease Diagnosis

Basic and Clinical Neuroscience
Molecular NeuroscienceNeurologyCellular
2019English

Biomarkers for Alzheimer's Disease

Journal of Alzheimer's Disease
GerontologyClinical PsychologyMental HealthPsychiatryGeriatricsMedicineNeuroscience
2006English

Diagnosis of Alzheimer's Disease

BMJ
1991English

CSF Biomarkers of Alzheimer Disease: "Noncognitive" Outcomes

Neurology
Neurology
2013English

Magnetic Resonance Imaging Biomarkers for the Early Diagnosis of Alzheimer's Disease: A Machine Learning Approach

Frontiers in Neuroscience
Neuroscience
2015English

The Impact of Preanalytical Variables on Measuring Cerebrospinal Fluid Biomarkers for Alzheimer's Disease Diagnosis: A Review

Alzheimer's and Dementia
Molecular NeuroscienceGerontologyHealth PolicyDevelopmental NeuroscienceMental HealthEpidemiologyGeriatricsCellularPsychiatryNeurology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy